Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell–engineered mesothelin-redirected CAR-NKT cells
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Proceedings of the National Academy of Sciences, Volume 122, Number 47, November 2025.
SignificancePancreatic cancer (PC) is one of the deadliest cancers, often diagnosed at advanced stages and difficult to treat. Current cellular therapies, such as CAR-T cells, face major obstacles, including tumor variability, immune escape, and limited scalability. …
